OTC Sedation Warning Effectiveness To Be Considered By FDA/NTSB
This article was originally published in The Tan Sheet
Executive Summary
The inability of consumers to recognize they have impaired motor skills after taking potentially sedating OTC antihistamines likely will be discussed at a joint FDA/National Transportation Safety Board meeting Nov. 14-15